Skip to main content

Table 3 Competing risk regression analysis of Cambridge Prognostic Groups (CPGs) in the PCBaSe cohort

From: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

CPG comparison

Sub-hazard ratio

95% confidence interval

p value

2 vs. 1

2.30

2.04–2.59

< 0.0001

3 vs. 2

2.11

1.89–2.36

< 0.0001

4 vs. 3

1.56

1.42–1.72

< 0.0001

5 vs. 4

2.72

2.58–2.88

< 0.0001

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us